BeStock  
Stocks › Biotechnology › MNPR

Monopar Therapeutics MNPR

US equityMarket cap rank #3666Biotechnology
$83.78 +$4.21 (+5.29%)
Pre-market · Oct 8, 9:00 am ET · After hours $83.80 +0.02%
Open$78.28
Prev close$79.57
Day range$77.98 – $85.03
Volume107.1K
Market cap$562.35M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-38.1x
CheapRich

Near the bottom of its 5-year range · 5th percentile, 5-year average -10.0x

Price / book4.3x
CheapRich

Above its usual level · 79th percentile, 5-year average 5.5x

#4128 of 5317 stocks by PB (1 = cheapest)

P/E over five years

-64x-40x-16x8xOct '21Apr '24Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$70.88
Price vs. fair value+18.2%Trading above the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 4.30 – 5.47 79% (pricier than usual) #4128 of 5317 (1 = cheapest)
PE -38.08 -14.60 -10.00 5% (cheaper than usual) –
PS – 409.28 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$70.88
Economic moatNone
UncertaintyVery High

Discussion

No comments yet — be the first to weigh in on MNPR.

Leave a comment

Scroll to Top